Subarachnoid Hemorrhage Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Effect of early stellate ganglion block in cerebral vasospasm after aneurysmal subarachnoid hemorrhage (BLOCK-CVS): study protocol for a randomized controlled trial
DiscussionThis is a randomized controlled trial to explore the effectiveness and safety of early stellate ganglion block as a preventive treatment to reduce cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. If the results are positive, it may provide a new direction for the prevention and treatment of cerebral vasospasm and delayed cerebral ischemia.Trial registrationThe study was registered on Clincaltrials.gov on December 13, 2020 (NCT04691271). (Source: Trials)
Source: Trials - November 4, 2022 Category: Research Source Type: clinical trials

The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study
Condition: Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage Interventions: Drug: Huperzine A injection, operational treatment, the best basic treatment; Other: operational treatment, the best basic treatment; Drug: Huperzine A injection, interventional treatment, the best basic treatment; Other: Interventional treatment, the best basic treatment Sponsors: Wanbangde Pharmaceutical Group Co., LTD; Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2022 Category: Research Source Type: clinical trials